Top 15 Companies in Global Colorectal Cancer Screening Market (2025–2035): Spherical Insights Analysis

Introduction

The global colorectal cancer screening market refers to the segment of the healthcare and diagnostic industry that focuses on screening methods used for the early detection of colorectal cancer. The screening solutions provide hospitals and diagnostic centers and home-based testing with reliable non-invasive preventive healthcare solutions. Colorectal cancer screening establishes a clinical method to identify cancer at its initial development stage which results in decreased death rates and better patient results and reduced expenses for prolonged medical treatment. The market is expanding steadily because of three factors which include increasing colorectal cancer rates and rising public knowledge about early diagnosis and growing use of modern screening methods. The combination of government programs which provide support and screening initiatives and reimbursement systems creates an environment that promotes people to undertake regular health assessments and preventive medical procedures. The development of diagnostic technologies through stool-based tests and colonoscopy procedures and imaging methods has resulted in improved diagnostic accuracy and testing convenience and patient adherence to medical advice. The growing aging population and increasing focus on preventive healthcare are further accelerating adoption. Colorectal cancer screening establishes a partnership with existing diagnostic and monitoring systems which leads to unified and effective healthcare administration. The cancer diagnostics market displays growth patterns that resemble those of the general healthcare industry because modern healthcare systems require early detection methods and advanced diagnostic tools for their operations.

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Colorectal Cancer Screening Market.

 

Market Segmentation

Global Colorectal Cancer Screening Market Size, Share, By Type (Stool-based, Colonoscopy, and Others), By End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostics Imaging Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2024 – 2035

 

Colorectal Cancer Screening Market Size & Statistics

• The Market Size for Colorectal Cancer Screening Was Estimated to be worth USD 18.4 Billion in 2024
• The Market is Going to Expand at a CAGR of 4.51% between 2024 and 2035.
• The Global Colorectal Cancer Screening Market Size is anticipated to reach USD 29.9 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the Colorectal Cancer Screening Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Colorectal Cancer Screening Market.

Regional growth and demand                                  

Asia Pacific is expected to grow the fastest during the forecast period in the colorectal cancer screening market. The growth of the market results from three main factors which include higher rates of colorectal cancer cases and the growing number of elderly people and the development of government-sponsored screening programs in countries like China and India and Japan.

 

North America is expected to generate the highest demand during the forecast period in the colorectal cancer screening market. North America dominated the cosmeceuticals market with a market share of 62.4% in 2024. The United States and Canada lead in this field because their colorectal cancer rate remains high and their developed healthcare system and advanced screening methods which include colonoscopy and stool tests have become widely used.

 

 

Top 10 Trends in the Colorectal Cancer Screening Market

• Rising prevalence of colorectal cancer worldwide
• Increasing focus on early detection and preventive healthcare
• Growing adoption of non-invasive screening tests (stool-based, liquid biopsy)
• Integration of AI and advanced diagnostics in screening
• Expansion of government screening programs and guidelines
• Shift toward home-based and remote screening solutions
• Technological advancements in colonoscopy and imaging
• Increasing geriatric population driving screening demand
• Growing awareness and healthcare expenditure globally
• Development of personalized and biomarker-based screening approaches

 

• Rising prevalence of colorectal cancer worldwide

The rising number of colorectal cancer cases which result from population aging and poor dietary choices and inactive living patterns has created a higher need for screening methods. The need for early detection has become essential because it helps decrease death rates while enhancing patient survival rates.

 

• Increasing focus on early detection and preventive healthcare

The healthcare systems together with governments are promoting systematic screening programs which enable early cancer detection. The combination of preventive healthcare programs with public awareness initiatives is motivating individuals to participate in regular screening assessments.

 

• Growing adoption of non-invasive screening tests

The convenience and cost-effectiveness of stool-based tests (FIT and FOBT) and liquid biopsies make them preferred options for patients who want non-invasive testing methods. The tests enable initial screening procedures which require fewer invasive tests than colonoscopy.

 

• Integration of AI and advanced diagnostics in screening

Artificial intelligence technology enables more precise and faster cancer detection results. The AI-powered tools utilize imaging and diagnostic data to support clinical decision-making processes while minimizing human error.

 

• Expansion of government screening programs and guidelines

Countries worldwide are establishing national screening systems and standardized guidelines to facilitate early colorectal cancer diagnosis. The combination of supportive policies with funding and reimbursement systems has resulted in increased participation rates which drive market expansion.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the colorectal cancer screening market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Colorectal Cancer Screening Market.

 

Top 15 Companies Leading the Colorectal Cancer Screening Market

1. Exact Sciences Corporation
2. F. Hoffmann-La Roche Ltd.
3. Siemens Healthineers
4. Olympus Corporation
5. Sysmex Corporation
6. Quest Diagnostics Incorporated
7. Abbott Laboratories
8. Danaher Corporation (Beckman Coulter)
9. Illumina, Inc.
10. Guardant Health, Inc.
11. Epigenomics AG
12. Eiken Chemical Co., Ltd.
13. FUJIFILM Holdings Corporation
14. Natera, Inc.
15. Polymedco Inc.

 

• Exact Sciences Corporation

Headquarters: Madison, Wisconsin, USA

Exact Sciences Corporation operates its international business operations in multiple countries while generating revenue from its core business which focuses on developing non-invasive diagnostic tests for Colorectal Cancer Screening. The company has developed advanced stool-based DNA tests which provide medical professionals with tools to detect colorectal cancer at its earliest stage. The company has developed a new method which helps patients follow their screening schedule more easily while making tests available to everyone. Exact Sciences uses its research facilities to create better testing methods while developing new products for their business. The company provides practical screening methods which help people detect cancer earlier while decreasing death rates from cancer throughout the world.

 

• F. Hoffmann-La Roche Ltd.

Headquarters: Basel, Switzerland

F. Hoffmann-La Roche Ltd. operates as a worldwide pharmaceutical and diagnostic company which actively participates in the Colorectal Cancer Screening business. The company provides multiple diagnostic testing options which include advanced molecular tests and immunochemical tests used for cancer diagnosis. Roche develops its business through innovative research and operational methods which create precise diagnostic systems and individual treatment options. The company establishes its worldwide network through advanced technological investments which enable efficient disease identification and management. Roche provides diagnostic solutions which help worldwide cancer detection programs to achieve better results for patients through improved diagnostic procedures.

 

• Siemens Healthineers

Headquarters: Erlangen, Germany

Siemens Healthineers establishes itself as a top medical technology firm which operates as a crucial force within the Colorectal Cancer Screening industry. The company provides advanced imaging systems, laboratory diagnostics, and AI-enabled healthcare solutions used in cancer detection. Its screening technologies find extensive application in hospitals and diagnostic centers which enables them to provide precise and speedy diagnostic results. Siemens Healthineers implements digital technologies and automated processes and develops personalized medicine approaches to improve healthcare operations. The company uses its extensive international presence to improve diagnostic methods while helping track early signs of colorectal cancer.

 

• Olympus Corporation

Headquarters: Tokyo, Japan

Olympus Corporation functions as a major medical device manufacturing company while establishing itself as an essential participant in the Colorectal Cancer Screening industry through its development of endoscopic solutions. The company offers advanced colonoscopy systems that enable direct visualization and early detection of colorectal abnormalities. Olympus provides high-quality imaging products together with precise diagnostic instruments which enable doctors to perform accurate assessments and safe minor surgical operations. The company focuses on developing new technologies which help healthcare organizations improve their efficiency for better patient results. The company establishes itself as a worldwide leader in colorectal cancer screening through its dominant position in endoscopy products.

 

• Sysmex Corporation

Headquarters: Kobe, Japan

Sysmex Corporation operates as an international healthcare organization which provides diagnostic testing solutions while maintaining a strong presence in the Colorectal Cancer Screening market. The company provides advanced testing systems which include fecal occult blood tests (FOBT) that medical professionals use for early detection of cancer. Sysmex develops diagnostic technologies through its research efforts which focus on innovation and automation and high-quality diagnostic systems to enhance operational efficiency and testing precision. The company distributes its products to laboratories and healthcare facilities which operate in every country around the globe. Sysmex supports dependable and easily accessible screening techniques which help medical professionals identify health conditions at earlier stages while promoting preventative health care methods.

 

Are you ready to discover more about the colorectal cancer screening market?

The report provides an in-depth analysis of the leading companies operating in the global colorectal cancer screening market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Exact Sciences Corporation

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. F. Hoffmann-La Roche Ltd.
2. Siemens Healthineers
3. Olympus Corporation
4. Sysmex Corporation
5. Quest Diagnostics Incorporated
6. Abbott Laboratories
7. Danaher Corporation (Beckman Coulter)
8. Illumina, Inc.
9. Others.

 

Conclusion

The global colorectal cancer screening market is witnessing steady growth because of three factors which include rising colorectal cancer rates and better public knowledge about early diagnosis methods and new diagnostic technologies. Colorectal cancer screening solutions provide cost-effective and reliable methods for early detection across hospitals, diagnostic centers, and home-based settings, helping to reduce mortality rates and improve patient outcomes. Screening techniques have improved through three new developments which include non-invasive stool-based tests and AI-powered diagnostic systems and advanced imaging technologies that provide better testing accuracy and simpler operation and faster testing results. The market experiences growth because government programs support national screening initiatives while more people choose preventive health care methods. Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Olympus Corporation, and Sysmex Corporation have become leading companies which establish their global presence by developing advanced diagnostic systems that strengthen their competitive position. Colorectal cancer screening enables early disease detection which results in better survival rates while it supports global healthcare systems that operate through efficient preventive methods.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter